These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. [L-tryptophan-associated chronic eosinophilia-myalgia syndrome treated with cyclosporin]. Schubert S; Trautmann F; Dreher R Z Rheumatol; 1992; 51(4):158-62. PubMed ID: 1414039 [TBL] [Abstract][Full Text] [Related]
30. Upper extremity contractures in a patient with eosinophilia-myalgia syndrome. Marchman HB; Gleason CB; Shaw JC Arch Phys Med Rehabil; 1991 Nov; 72(12):1029-30. PubMed ID: 1953317 [TBL] [Abstract][Full Text] [Related]
31. [Peripheral neuropathy unmasked by therapy with adrenal cortex hormones during myalgia-eosinophilia syndrome related to L-tryptophan]. Moreaud O; Mezin P; De Saint Victor JF; Noelle B; Berger F; Pellat J Presse Med; 1994 Jun; 23(24):1138. PubMed ID: 7971839 [No Abstract] [Full Text] [Related]
32. The eosinophilia-myalgia syndrome and tryptophan. Belongia EA; Mayeno AN; Osterholm MT Annu Rev Nutr; 1992; 12():235-56. PubMed ID: 1503805 [No Abstract] [Full Text] [Related]
33. Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome. Kilbourne EM; Philen RM; Kamb ML; Falk H J Rheumatol Suppl; 1996 Oct; 46():81-8; discussion 89-91. PubMed ID: 8895184 [TBL] [Abstract][Full Text] [Related]
34. Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique. Shapiro S J Rheumatol Suppl; 1996 Oct; 46():44-58; discussion 58-9. PubMed ID: 8895181 [TBL] [Abstract][Full Text] [Related]
35. L-tryptophan syndrome: histologic features of scleroderma-like skin changes. Guerin SB; Schmidt JJ; Kulik JE; Golitz LE J Cutan Pathol; 1992 Jun; 19(3):207-11. PubMed ID: 1401345 [TBL] [Abstract][Full Text] [Related]
36. Clinical improvement of the myopathy in eosinophilia-myalgia syndrome with steroids and rehabilitative therapy. Esper JJ; Nigro MA; Wishnow R; Barnett T; Perrotta AL; Richardson W J Am Osteopath Assoc; 1992 Aug; 92(8):1056-8. PubMed ID: 1429067 [TBL] [Abstract][Full Text] [Related]
37. Delayed onset of skin fibrosis after the ingestion of eosinophilia-myalgia syndrome-associated L-tryptophan. Greenberg AS; Takagi H; Hill RH; Hasan A; Murata H; Falanga V J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):264-6. PubMed ID: 8708033 [No Abstract] [Full Text] [Related]
38. L-tryptophan-related eosinophilia-myalgia syndrome possibly associated with a chronic B-lymphocytic leukemia. Böhme A; Wolter M; Hoelzer D Ann Hematol; 1998 Nov; 77(5):235-8. PubMed ID: 9858150 [TBL] [Abstract][Full Text] [Related]
39. Eosinophilic hepatitis: a new feature of the clinical spectrum of the eosinophilia-myalgia syndrome. Martinez-Osuna P; Espinoza CG; Cuellar ML; Cabrera GE; Silveira LH; Espinoza LR Clin Rheumatol; 1994 Sep; 13(3):528-32. PubMed ID: 7835024 [TBL] [Abstract][Full Text] [Related]
40. L-tryptophan and the eosinophilia-myalgia syndrome: a clinical and laboratory study. McKeon P; Swanwick G; Manley P Acta Psychiatr Scand; 1994 Dec; 90(6):451-4. PubMed ID: 7892779 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]